Clinical evaluation of desensitizing treatments for cervical dentin hypersensitivity
AUTOR(ES)
Aranha, Ana Cecilia Corrêa, Pimenta, Luiz André Freire, Marchi, Giselle Maria
FONTE
Brazilian Oral Research
DATA DE PUBLICAÇÃO
2009-09
RESUMO
The aim of this study was to compare different treatments for dentin hypersensitivity in a 6-month follow-up. One hundred and one teeth exhibiting non carious cervical lesions were selected. The assessment method used to quantify sensitivity was the cold air syringe, recorded by the visual analogue scale (VAS), prior to treatment (baseline), immediately after topical treatment, after 1 week, 1, 3 and 6 months. Teeth were randomly assigned to five groups (n = 20): G1: Gluma Desensitizer (GD); G2: Seal&Protect (SP); G3: Oxa-gel (OG); G4: Fluoride (F); G5: Low intensity laser-LILT (660 nm/3.8 J/cm²/15 mW). Analysis was based on the non-parametric Kruskal-Wallis test that demonstrated statistical differences immediately after the treatment (p = 0.0165). To observe the individual effects of each treatment, data was submitted to Friedman test. It was observed that GD and SP showed immediate effect after application. Reduction in the pain level throughout the six-month follow-up was also observed. In contrast, LILT presented a gradual reduction of hypersensitivity. OG and F showed effects as of the first and third month respectively. It can be concluded that, after the 6-month clinical evaluation, all therapies showed lower VAS sensitivity values compared with baseline, independently of their different modes of action.
Documentos Relacionados
- Desensitizing treatments for dentin hypersensitivity: a randomized, split-mouth clinical trial
- Effects of different desensitizing treatments on root dentin permeability
- Avaliação clínica de diferentes protocolos no tratamento da hipersensibilidade dentinária cervical
- Dentin hypersensitivity after treatment with desensitizing agents: a randomized, double-blind, split-mouth clinical trial
- Evaluation of dentin hypersensitivity treatment with glass ionomer cements: A randomized clinical trial